Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Chronic finasteride use in male rats doesn't strongly cause depression or anxiety due to adaptive stress hormone changes.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Escitalopram helped a woman with hair-pulling due to long COVID.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Stopping SSRIs can reverse hair loss in some patients.

Some antidepressants can cause rare hair loss, which can significantly affect patients' well-being.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

5α-Reductase inhibitors don't cause depression.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.